Repeated specific canine pancreatic lipase measurements do not identify multiple acquired portosystemic shunts in dogs after extrahepatic portosystemic shunt attenuation
Journal of Veterinary Internal Medicine · 2023
DOI: 10.1111/jvim.16781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2023. Verfasst von Gonçalo Serrano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Small Animal Department, Ghent University, Faculty of Veterinary Medicine, Merelbeke, Belgium. Hauptthemen laut MEDLINE: Portasystemic Shunt, Transjugular Intrahepatic, Dog Diseases, Hypertension, Portal, Vascular Malformations. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
In dogs with portal hypertension (PH), spec cPL is suggested to be increased despite normal pancreatic histology. After attenuation of congenital extrahepatic portosystemic shunts (cEHPSS), multiple acquired portosystemic shunt (MAPSS) can develop as consequence of sustained PH. Presence of MAPSS affects future therapeutic options and prognosis.
Objective
Evaluate if spec cPL concentrations increase postoperatively in dogs that develop MAPSS and can thus serve as an indicator of PH. Animals Twenty-four dogs with cEHPSS.
Methods
Dogs classified according to surgical outcome after cEHPSS attenuation (8 with MAPSS [group M], 9 with closed cEHPSS [group C] and 7 with patent blood flow through the original cEHPSS, without evidence of MAPSS [group P]). Spec cPL was measured in preoperative samples (T0), 4 days (T1) and 1 (T2) and 3- to 6-months (T3) after surgery.
Results
Spec cPL was within reference interval (<200 μg/L) at all timepoints except at T1. At T1, 2 dogs in group M (321 and >2000 μg/L) and also 1 in group C (688 μg/L) and 1 in group P (839 μg/L) had increased spec cPL concentrations. No differences in spec cPL concentrations between groups or changes over time were identified. Conclusions and Clinical Importance Spec cPL is not consistently increased in dogs that develop MAPSS after cEHPSS attenuation and has no potential as a biomarker for the identification of MAPSS after cEHPSS attenuation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Small Animal Department, Ghent University, Faculty of Veterinary Medicine, Merelbeke, Belgium.
- Evidensia Hart van Brabant, Waalwijk, Netherlands.
ORCID-Profile: Gonçalo Serrano, Nausikaa Devriendt, Hilde de Rooster
Zitieren
APA
Serrano, G., Devriendt, N., & de Rooster, H. (2023). Repeated specific canine pancreatic lipase measurements do not identify multiple acquired portosystemic shunts in dogs after extrahepatic portosystemic shunt attenuation. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16781
Vancouver
Serrano G, Devriendt N, de Rooster H. Repeated specific canine pancreatic lipase measurements do not identify multiple acquired portosystemic shunts in dogs after extrahepatic portosystemic shunt attenuation. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16781
BibTeX
@article{Serrano2023,
author = {Serrano, Gonçalo and Devriendt, Nausikaa and de Rooster, Hilde},
title = {Repeated specific canine pancreatic lipase measurements do not identify multiple acquired portosystemic shunts in dogs after extrahepatic portosystemic shunt attenuation},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
doi = {10.1111/jvim.16781}
}
EUVIMED